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In order to explore intraeellular signaling pathways ot" the mitogenic a tion of endothelin (ET), we examin~ the effect of ET on activities of 
extracetlular signal-regulated kina~es (ERKs) in rat aortic smooth muscle cells (SMCs). Treatment of rat aortic SMCs with ET-1 increased kina~ 
activities toward myelin basic protein (IMBP). Both 43- and 41-kDa proteins were aetivaled when kinase assays were done in MBP-eontaining 
polyacr),lamide gels after SDS-PAGE. These proteins were identified as ERKI and ERK2 with immunoprecipitation and immunoblotting using 
antipeptide antibodies, re~pextively. These results indicate that ERK~ mediate signal transduetion by ET. 
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1. INTRODUCTION 
Endothelin (ET) was initially identified as a potent 
vasoconstrictor peptide produced by porcine vascular 
endothelial cells [1]. Analysis of  the human El" gene 
revealed that ETs comprise a peptide family consisting 
of three isopeptides, ET-1, ET-2 and ET-3, which have 
subsequently been shown to have various effects on 
both vascular and non-vascular tissues [2,3]. Pharma- 
cological studies and binding experiments have sug- 
gested the existence of multiple ET receptor (ETR) sub- 
types [4--6]. Subsequent molecular cloning studies have 
proved the existence of at least two ETR subtypes, ET- 
1-selective receptor and non-isopeptide.selective rec p- 
tor, designated ETAR and ETBR, respectively [7,8]. 
Northern blot analysis of  vascular tissues and cells with 
the cloned receptor eDNA probes showed that the 
major subtype of  ETR in vascular smooth muscle cells 
(SMCs) is ETAR [9,10], while the ET~R subtype is pre- 
dominantly expressed in vascular endothelial cells [11]. 
ET has been shown to stimulate DNA synthesis and 
increase cell numbers of  cultured vascular SMCs [12- 
15]. ETR is coupled to phospholipase C, and ErR  stim- 
ulation leads to activation of protein kinase C in many 
systems, including cultured vascular SMCs [16]. The 
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mitogenic effect of ET has been demonstrated to be 
dependent, in part, on protein kinase C, because the 
promoting effect of ET on DNA synthesis was attenu- 
ated but not abolished in phorbol ester-pretreated, pro- 
tein kinase C-depleted cells [14,15]. However, little is 
known about either the signal transduetion mechanism 
acting downstream of protein kinase C or the protein 
kinase C-independent mito~enic signaling pathways. 
Mierotubule-associated protein 2 (MAP2) kinase or 
mitogen-activated protein (MAP) kinase, or myelin 
basic protein (MBP)/MAP2 kinases is/are rapidly stim- 
ulated in response to a variety of growth factors and 
other extracellular signals [17-27]. Their activation is 
accompanied by their phosphorylation  tyrosine, as 
well as serine/threonine residues, indicating their regula- 
tory roles in a growth factor-dependent protein kinase 
cascade [18,20]. Recently, Boulton et al. reported the 
eDNA cloning of two related enzymes of extracellular 
signal-regulated kinases (KRKI and ERK2, respec- 
tively) which are thought o encode MBP/MAP2 ki- 
nases [27,28], and the third related kinase, ERK3 [29]. 
In the present study we have identified two ERK 
isozymes, ERK1 and ERK2, in rat aortic SMCs, using 
two antibodies for immunoprecipitation and im- 
munoblotting, one raised against he synthetic peptide 
corresponding to the C-terminal portion of the deduced 
amino acid sequence of the ERK 1 and the other against 
the peptide containing the putative a'atophosphoryla- 
tion sites of tile amino acid sequence deduced from the 
ERK2 eDNA. We have also examined the effects of ET 
on activities of ERKs in rat aortic SMCs in order to 
elucidate the possible participation of ERKs in intracel- 
lular signaling pathways of ETRs. 
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2. MATERIALS AND METHODS 
2.1. Pepticfe s_wrrhesis cmci prodrrction ofnnrisera 
The peptide, ELIFQETARFQPGAPEAP (p&de IC), and the 
pcptidc, RIEYEQ ALAHPYLEQYYDPSDEP (peptide ZY), which 
correspond to residues 350-367 and 299-321 of the amino acid se- 
quence deduced from the ERKl and ERK2 cDNA, respectively, were 
synthesized c;ccc:ding :o :h;o solid-phase synthesis technique. The pep- 
tides (3 mg) were conjugated to bovine thyroglobulin (Sigma) (15.0 
mg) using the carbodiimidc oupling procedure [30]. The conjugate 
was emulsified with complete Freund’s adjuvant and injected subcuta- 
neously into multiple sites of female New Zealand White rabbits. 
Rabbit serum was collcrted aider a number of booster injections. The 
antisera gainst pcptidc IC and peptide 2Y were termed ICantiserum 
and 2Y antiserum, respectively. 
2.2. Cell nrfttrre and prepmarion of celf exlrf;cIs 
Rat aortic SMCs were prepared from explnnts of tboracic aorta of 
20.week-old male Wistar rats and cultured according to the method 
plzviously described [31]. SMCs between the sevcntb and ninth pas- 
sages were used. Chinese hamster ovary (CHO) cells were grown in 
a-minimum essential medium (Gibco) supplemented with 10% fetal 
calf serum. Cells were rendered quiescent by placing them in serum- 
free medium for 48 h. After treatment of the quiescent rat aortic SMCs 
with various concentrations ofET isopeptides (Peptidc Institute, Inc., 
Minoh, Japan) for the indicated times, cells were lysed with 0-B ml of 
lysis buffer containing 25 mM Tris-HCI (pH 7.6), 20 mM NaCI, 1 mM 
sodium orthovanadate, 10 mM NnF, IO mM sodium pyrophosphate, 
0.5 mM EGTA and 0.1 mM PMSF. 
2.3. Kinase assuys 
Kinase assays toward MBP were performed at 30°C for 20 min in 
a final volume of 50~1 containing 10 mM MgCII, i0 PM ATP, 4 PM 
protein kinasc inhibitor peptide (rabbit sequence) (Sigma), MBP 
(Sigma) (400 yg/ml), 1 yCi of [y-“P]ATP (Amersham Corp.) and the 
cell extract (30 ~1). The reaction was stopped by adding 50 ,ul of 2 x 
Laemmli’s ample buffer, and the samples were subjected to SDS- 
PAGE and autoradiography. The bands corresponding to the sub- 
strate were excised from the dried gels and the radioactivity was 
determined using a scintillation counter. 
Kinase assays in MBP-containing polyacrylamide gels were carried 
out according to the method of Kamcshita nd Fujisawa [32]. The cell 
extracts were electrophoresed on an SDS-polyacrylamide g l contain- 
ing 0.5 mg/ml MBP. SDS was removed from the gel by washing the 
gel with two changes of 25 ml each of 20% 2-propanol in 50 mM 
Tris-HC1 (pH 8.0) for I h and then 250 ml of 50 mM Tris-HCI (pH 
B.O)containing 5 mM 2-mercaptoethanol for1 hat room temperature. 
The enzyme was denatured by treating lhe gel tirst with two changes 
of 25 ml ofG M guanidine-HCI at room temperature for 1 h and then 
renatured with four changes of 250 ml each of 50 mM Tris-HCI (p1-I 
8.0) containing 0.04% Tween 40 and 5 mM 2-mercaptoethanolat 4OC. 
After renaturation, the gel was preincubated at30°C for 30 min with 
25 ml of40 mM Tris-I-ICI (pH 8.0) containing 2 mM dithiothreitol and 
10 mM M&II. The gel was incubated at 30°C for I h with 28 ml of 
40 mM Tris-HCl (pH 8.0), 50 mM NaCI, 20 mM KCI, ICI mM M&I,, 
0.1 mM EGTA, 2 mM dithiothreitol, 50 ,uM ATP, and 10 ,uCi of 
[$qATP. After incubation, the gel was washed with a 5% (w/v) 
trichloroacetic acid solution containing 1% pyropbosphatc until the 
radioactivily of the solution became negligible. The washed gel was 
dried and then subjected to autoradiography. 
2.4. Ir,lnlunoprec~ilarion rend We,stern Bforring 
The 1~11 lysate was subjected to immunoprccipitation with IC an& 
serum diluted 20-fold, and incubated for I h at 4OC after which 50~1 
of protein A-agarose (Pharmacia) was added. After 2 b of incubation 
at 4’C, the imrnl;;:oprecipitatcs were washed twice with lysis buffer, 
The kinase activity of the immunoprecipitatcs was assayed in MBP- 
containing polyacrylamide gels as described above. The cell lysate was 
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subjected to SDS-PAGE and transferred to nitrocellulose sheets. They 
were incubated with each antibody, and proteins immunoreacting with 
antisera were detected osing [1z51]protein A (Amewham Corp.). 
3. RESULTS AND DlSCUSSION 
3.1. Ciwacrerimion of artrisera 
Antisera were generated to two peptides predicted by 
the ERKI and ERK2 cDNA. The specificity of antisera 
was determined by immunoblotting as shown in Fig. 
1A. When cell extracts from CHO cells were blotted 
with antisera, one antibody against he C-terminai pep- 
tide of ERIC1 recognized a43-kDa band almost specif- 
ically (Fig. IA, lane a). The other antibody raised 
against he ERIC2 peptide, containing a sequence which 
resembles the regulatory autophosphorylated region of 
the insulin receptor, recognized 41- and 43-kDa pro- 
teins, although it probed the 41-kDa protein more effi- 
ciently (Fig. lA, lane c). Recognition of the bands at 43 
and 41 kDa was significantly blocked by preincubation 
of the antibodies with peptide antigens, demonstrating 
the specificity of the interaction of the antibodies with 
these proteins (Fig. 1 A, lanes b and d), We conclude 
that the 43- and 41-kDa proteins correspond to ERKl 
and ERK2, respectively, based on the relative specificity 
of the antisera raised against ERKl and ERK2 pep- 
tides. This result is consistent with that of Boulton et al. 
who showed that the ERKI and ERK2 gene products 
are highly related to the 43- and 41-kDa MBP/MAP2 
kinases, respectively, using antibodies against ERKl 
peptides and recombinant ERK2 protein [33]. Since 2Y 
antiserum was unable to immunoprecipitate significant 
amounts of the 43- and 41-kDa proteins under non- 
denaturing conditions, in the following experiments im- 
munoprecipitation was done with the 1C antiserum, 
which is specific for the 43-kDa protein. 
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Fig. 1. Western blotting with antipcptide antibodies against ERKs. 
(A) Specificity of the anlipcptide antibodies. Cell lysatcs from CHO 
cells wcrc subjected to SDS-PAGE followed by Western blotting with 
antisera IC (lane a) and 2Y (lane c) or the antibodies which had been 
preincubated with each of 5OOpM peptides (lanes b and d). (B) West- 
ern blotting of cell lysates from rat aortic SMCs. The lysates were 
subjected to SDS-PAGE followed by immunoblotting with antisera 
1C (lane a) and 2Y (lane b). 
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Fig. 2. Dose-response curve of ET-I stimulntion of kinase activity 
toward MBP in the cell lysate of rat aortic SMCs. Rat aortic SMCs 
were treated with the indicated concentrations of ET-1 for 5 min at 
37°C The cells were lysed and the cell lysate was subjected to kinasc 
assays toward MBP. The bands u’erc excised and counted by Cer- 
cnkov counting. 
3.2. IdenriJication of muitip!e ERKS in rat aortic SMCs 
The ceil lysates from rat aortic SMCs were im- 
munoblottcd with the two antisera; 1C antiserum, 
which has selectivity for ERIC], and 2Y antiserum, 
which recognizes both ERKl and ERK2 with a higher 
affinity for ERKZ. As shown in Fig. iB, 1C antiserum 
recognized aband at 43 kDa, while 2Y antiserum recog- 
nized a band at 41 kDa, and a band at 43 kDa with less 
intensity, identifing ERK isozymes in rat aortic SMCs 
(Fig 1l3, lanes a and b). 
3.3. Activation ofkinase activity toward MBP by ET in 
rat aoriic SMCs 
Treatment of rat aortic SMCs with ET-1 increased 
kinase activity toward MBB. The activation was de- 
pendent on the ET-l concentration, as shown in Fig. 2. 
The concentration required for half-maximal activation 
was 5 x lO-1o ET-l. ET-3 at a concentration of 1Om8 M 
did not increase kinase activity toward MBP (data not 
shown). This result suggests that ET-induced activation 
of kinase activity toward MBP may be mediated via 
ET,R with selectivity for ET-l, which is predominantly 
expressed in vascular SMCs. 
Maximal activation was almost attained 2-5 min 
after the addition of lO_’ fA FT ’ l v* k*-, .o .UC bbY...W L .L rot onrt;.- cy(-+-+_ 
The activated kinase activity was then reduced to nearly 
basal evels within 30-GO min (data not shown). 
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Fig. 3. Kinasc assays of the cell lysate from rat aortic SMCs in MBP- 
containing gels after SDS-PAGE. The rat aortic SMCs were treated 
either without or with IO-” M ET-I or IO-” M ET-3 for 5 min and 
lyscd. The lysates were cleclrophoresed on SDS-polyacrylamide g ls 
containing MBP. SDS was removed from the gel, and after denatuw- 
tion with 6 M guanidine-HCI and renaturation i  buffer containing 
0.04% Tween 40, the gel was incubated with [y-“P]ATP nnd Mg”’ as 
described in Mar&a:-, and Melhods. The MBP kinase activity mi- 
grating at 41 kDa was measured by densitometric scanning or the 
autoradiogmm. 
3.4. Identification of ET-I-stitnulated kinase activity in 
rat aorric SMCs as ERKs 
To directly determine the molecular masses of the 
proteins responsible for the ET-l-stimulated kinase ac- 
tivity toward MBP, kinase assays in MBP-containing 
polyacrylamide gels after SDS-PAGE were done. The 
cell lysates of ET-l- and ET3-treated or untreated cells 
were electrophoresed on an SDS-polyacrylamide gel 
containing MBP. As shown in Fig. 3, increased MBP 
kinase activities migrating at 43 and 41 kDa were ob- 
served after ET-l treatment but not. following ET-3 
treatment, he molecular masses of which are consistent 
with those of ERKI and ERK2, respectively. Both pro- 
teins were stimulated by ET-l in a coordinate fishion. 
The MBP kinase activities, having molecular masses of 
approximately 100 kDa and 64 kDa, appeared to be 
stimulated by ET-l. Since the deduced amino acid se- 
quence of the ERK3 predicts a protein of 63 kDa [29], 
the 64-kDa MBP kinase activity which apparently was 
stimulated by ET-1 in rat aortic SMCs may be closely 
related to ERK3. However, additional study is required 
to identify these MBP kinase activities. 
When cell lysates from ET-l- and ET-3-treated or 
untreated cells were subjected to immunoprecipitation 
with IC antiserum and the kinase assay of immunopre- 
cipitates was done in MBP-containing gels, the MBP 
kinase activity migrating at 43 kDa was stimulated by 
ET-1 (Fig. 4). These results, coupled with those of ki- 
nase assays of cell lysates in MBP-containing els, have 
197 
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Fig:. 4. Kinase assays of immunoprccipitates with the lC antiserum in 
MBP-containing els after SDS-PAGE, Rat aortic SMCs were treated 
either without or with lo-” M ET-I or IO-$ M ET-3 for 5 min. The 
cells were lysed and immunoprecipitated with IC antiserum. The ki- 
nase assays ofimmunoprecipitates were done as described in Materials 
and Methods. The MBP kinase activity in immunoprccipitatcs was 
measured by densitomelric scanning of the autoradiogram. 
clearly shown that ET-l-induced activation of MBP ki- 
nase activities is due to the coordinate activation of the 
ERK isozymes, ERKl and ERK2, in rat qortic SMCs, 
In the present study we have identified ERK isozymes 
and demonstrated their activation in response to ET in 
rat aortic SMCs, indicating that ERKs act as intermedi- 
ates in signaling pathways of ETRs. The precise role of 
ERKs in ET action in SMCs must await further studies. 
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